GeneSense Technologies Inc., Lorus deal

LOR completed its acquisition of GeneSense for C$13.3 million (US$9 million) in stock (see BioCentury, April 19). LOR and GeneSense shareholders own a third of the combined company, and investors in LOR's October C$10 million (US$6.8 million) financing own the balance (see BioCentury, Nov.1). ...